|Bid||38.66 x 1800|
|Ask||38.67 x 3100|
|Day's Range||38.59 - 38.85|
|52 Week Range||33.26 - 42.68|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||16.23|
|Earnings Date||Feb 01, 2017 - Feb 06, 2017|
|Forward Dividend & Yield||2.20 (5.63%)|
|Ex-Dividend Date||Aug 19, 2021|
|1y Target Est||48.04|
To expedite the search and process, the pharmaceutical company isn't the entity who signed the lease with Brandywine Realty Trust.
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks initially suffered […]
Johnson & Johnson (NYSE: JNJ) recently announced positive results from a phase 2 study of its RSV vaccine candidate. In this Motley Fool Live video recorded on Oct. 6, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not J&J set a high bar for Pfizer (NYSE: PFE) and GlaxoSmithKline (NYSE: GSK) to top.